Orchid Chemicals completes transaction with HospiraIllustrative image – not actual.

Orchid Chemicals & Pharmaceuticals has completed the transaction for sale and transfer of its generic injectable finished dosage forms pharmaceuticals business to Hospira Healthcare India.

The company had entered into a business transfer agreement on 15 December 2009, to sell its injectable business to Hospira for $400 million (approx Rs 1,860 crore). The transaction includes Orchid's betalactam antibiotics injectables manufacturing complex and formulations R&D facility at Irungattukottai, Chennai.

← All latest storiesBack to top →